Clinical trial NCT04846205: Relationship Between Sleep Apnea Syndrome and Patent Foramen Ovale Among Victims of Cryptogenic Ischemic Stroke
Official title: Assessment of the Relationship Between Sleep Apnea Syndrome and Patent Foramen Ovale Among Young Subjects Victims of Cryptogenic Ischemic Stroke
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Apnea Syndrome
Stroke
Keywords: obstructive sleep apnea syndrome
permeable foramen oval
Lead sponsor: Centre Hospitalier Universitaire de Saint Etienne
Sponsor class: OTHER
First posted: 2021-04-15
Enrollment: 159
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients who underwent a systematic etiological assessment in the context of their cryptogenic ischemic stroke between 2015 and 2020.

Brief summary: Obstructive sleep apnea syndrome (OSAS) and patent foramen ovale (FOP) are considered as risk factors for stroke. OSAS generates a pressure increase in the right cavity during inspiratory efforts, which increases the number of right-left shunt embolus and therefore the risk of stroke. OSA and FOP are often thought as two separate entities, however, due to their high frequencies, they sometimes coexist and can influence the pathophysiology of each other. More researches are needed in this area to confirm this complex association and its role in triggering stroke.

Detailed description: Obstructive sleep apnea syndrome (OSAS) and patent foramen ovale (PFO) are considered as risk factors for stroke. In most cases, the presence of FOP has no clinical impact. Certain hemodynamic conditions inducing a right-left pressure gradient can promote the reopening of a FOP and allow the passage of blood, presenting micro or macro-thrombi, from the venous system to the arterial system, explaining the mechanism of paradoxical embolism. OSAS generates a pressure increase in the right cavity during inspiratory efforts, which increases the number of right-left shunt embolus and therefore the risk of stroke. OSA and FOP are often thought as two separate entities, however, due to their high frequencies, they sometimes coexist and can influence the pathophysiology of each other. Evidence of a clinically significant interaction and causation in the genesis of stroke remains limited. More researches are needed in this area to confirm this complex association and its role in triggering stroke.

Eligibility criteria: Inclusion Criteria:

- Patients who have had a cerebral or retinal infarction confirmed by brain imaging or a defined transient ischemic attack without an identifiable cause after a detailed etiological assessment

Exclusion Criteria:

* Identification of a cause of ischemic stroke:

  * Atheromatous stenosis \> 50% (or atherosclerotic plaque \< 50% threatening) of supra aortic trunk or intracranial arteries on echodoppler of the supra aortic trunk and transcranial or scanner angiography.
  * Emboligenic heart disease : atrial fibrillation and atrial flutter, thrombus in left atrium, spontaneous contrast in left atrium, decreased atrial flow, left ventricular ejection fraction (LVEF) \< 40%, LV aneurysma, left intraventricular thrombus, recent myocardial infarction, cardiomyopathy ventricular dilated left with LVEF \< 35%, mitral stenosis, prosthetic mitral or aortic valve, infectious and non-infectious endocarditis, valve or mural tumor, complicated aortic arch atheroma (plaque \> = 4 mm, ulcerated plaque, thrombus on plaque), aortic dissection
  * Lacunar infarction symptomatic = \< 1.5 cm on the CT scan, = \< 2 cm on the diffusion MRI or the FLAIR.
  * No atherosclerotic arteriopathy : dissection, primary and secondary angitis, spastic angiopathy, etc...
  * Coagulopathy to come a long-term anticoagulant treatment (\> 6 months) (anti-phospholipid syndrome, thrombophilia).
  * Blood disorders and cancer
  * Recent intravenous drug use (in the 6 months before the stroke).
  * Other potential causes:
* Severe respiratory impairment or pulmonary arterial hypertension

Primary outcomes:
measure: Apnea hypopnea index
timeFrame: 1 year after the ischemic stoke
Secondary outcomes:
measure: Presence of foramen oval
timeFrame: 1 year after the ischemic stoke
Other outcomes:
Locations:
city: Saint-Étienne
country: France
facility: CHU de Saint-Etienne
Study officials:
affiliation: CHU de Saint-Etienne
name: Jean-Philippe CAMDESSANCHE, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: